ARTICLE | Company News
Fusion to identify cancer candidates with Isogenica platform
May 4, 2018 4:28 PM UTC
Isogenica Ltd. (Little Chesterford, U.K.) granted Fusion Pharmaceuticals Inc. (Hamilton, Ontario) rights to Isogenica's CIS display technology which Fusion will use to identify and develop cancer therapeutics. Isogenica will receive an undisclosed upfront payment and is eligible for undisclosed development milestones...